risks
![CAR T-cell therapy, blood cancer treatment, immunotherapy, personalized targeting, breakthrough, benefits, risks, approved therapies, leukemia, lymphoma, multiple myeloma,](https://pharmtales.com/wp-content/uploads/2023/08/CAR-T-Cell-Therapy-in-Hematological-Malignancies.jpg)
CAR T-Cell Therapy in Hematological Malignancies: A Breakthrough or a Bust?
Anika Sharma
Hematological malignancies are cancers that affect the blood, bone marrow, and lymph nodes. They include leukemia, lymphoma, and multiple myeloma. ...
Hematological malignancies are cancers that affect the blood, bone marrow, and lymph nodes. They include leukemia, lymphoma, and multiple myeloma. ...